Trials Trials, Vol 20, Iss 1, Pp 1-13 (2019) Uccelli, A, Laroni, A, Brundin, L, Clanet, M, Fernandez, O, Nabavi, S M, Muraro, P A, Oliveri, R S, Radue, E W, Sellner, J, Soelberg Sorensen, P, Sormani, M P, Wuerfel, J T, Battaglia, M A, Freedman, M S, Bonetti, B, Rush, C, Herrera, C, Ramo Tello, C, Miller, D, Szwajcer, D, Strunk, D, Wall, D, Aguera-Morales, E, Rohde, E, Dazzi, F, Comi, G, Martino, G, Izquierdo Ayuso, G, Rabinovitch, H, MacLean, H, Marriott, J, Racosta, J, Arab, L, Gimona, M, Introna, M, Blinkenberg, M, Aghdami, N, Ali, R, Vosoughi, R, Nicholas, R, Marrie, R A & Karimi, S 2019, ' MEsenchymal StEm cells for Multiple Sclerosis (MESEMS) : a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis ', Trials, vol. 20, 263 . https://doi.org/10.1186/s13063-019-3346-z